$41.36
al cierre: Aug 20 EDT
$41.70
0.340.82%
Pre-comercialización: 7:59 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Rigel Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$0.210
Estimación de ingresos trimestrales
$50.55M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$267.92M
Analice el historial de beneficios de Rigel Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RIGL | Rigel Pharmaceuticals | $0.70 | $0.21 | — | — | $55.31M | $50.55M | — | — | 11/06/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.06 | $0.19 | $3.28 | 101.23% | $36.84M | $48.14M | $101.69M | 35.43% | 08/05/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.50 | $0.24 | $0.63 | 600.00% | $29.53M | $51.16M | $53.30M | 21.50% | 05/06/2025 | |
RIGL | Rigel Pharmaceuticals | $0.04 | $0.20 | $0.80 | 45.45% | $35.79M | $48.32M | $57.60M | 0.01% | 03/04/2025 | |
RIGL | Rigel Pharmaceuticals | -$0.30 | $0.06 | $0.70 | 1066.67% | $28.13M | $41.93M | $55.31M | 31.90% | 11/07/2024 | |
RIGL | Rigel Pharmaceuticals | -$0.38 | -$0.29 | -$0.06 | 79.31% | $26.89M | $33.42M | $36.84M | 10.24% | 08/06/2024 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.30 | -$0.50 | -66.67% | $26.07M | $31.28M | $29.53M | -5.58% | 05/07/2024 | |
RIGL | Rigel Pharmaceuticals | $0.10 | -$0.30 | $0.00 | 100.00% | $51.28M | $34.10M | $35.79M | 4.96% | 03/05/2024 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$0.70 | -$0.30 | 57.14% | $22.41M | $27.20M | $28.13M | 3.43% | 11/07/2023 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$0.80 | -$0.40 | 50.00% | $29.82M | $26.02M | $26.89M | 3.33% | 08/01/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.60 | -$1.00 | -$0.80 | 20.00% | $16.73M | $24.07M | $26.07M | 8.31% | 05/02/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.10 | $0.10 | 109.09% | $20.41M | $27.97M | $51.28M | 83.33% | 03/07/2023 | |
RIGL | Rigel Pharmaceuticals | -$1.20 | -$1.30 | -$1.10 | 15.38% | $21.54M | $22.61M | $22.41M | -0.88% | 11/03/2022 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.20 | -$0.80 | 33.33% | $26.27M | $23.65M | $29.82M | 26.08% | 08/02/2022 | |
RIGL | Rigel Pharmaceuticals | $2.20 | -$1.40 | -$1.60 | -14.29% | $81.02M | $17.54M | $16.73M | -4.59% | 05/03/2022 | |
RIGL | Rigel Pharmaceuticals | -$1.10 | -$1.30 | -$1.10 | 15.38% | $18.45M | $21.90M | $20.41M | -6.81% | 03/01/2022 | |
RIGL | Rigel Pharmaceuticals | -$0.80 | -$1.00 | -$1.20 | -20.00% | $18.39M | $23.56M | $21.54M | -8.56% | 11/02/2021 | |
RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$0.80 | 27.27% | $16.02M | $20.37M | $26.27M | 28.94% | 08/03/2021 | |
RIGL | Rigel Pharmaceuticals | $1.30 | — | $2.20 | — | $55.76M | $31.05M | $81.02M | 160.93% | 05/05/2021 | |
RIGL | Rigel Pharmaceuticals | -$1.00 | -$1.10 | -$1.10 | 0.00% | $15.40M | $18.10M | $18.45M | 1.93% | 03/02/2021 | |
RIGL | Rigel Pharmaceuticals | -$0.70 | — | -$0.80 | — | $9.14M | — | $18.39M | — | 11/05/2020 |
Rigel Pharmaceuticals (RIGL) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $3.28 | $0.19 | 101.2 % |
| Q1 | 2025-05-06 | $0.63 | $0.24 | 600.0 % |
| Q4 | 2025-03-04 | $0.80 | $0.20 | 45.5 % |
| Q3 | 2024-11-07 | $0.70 | $0.06 | 1066.7 % |
Rigel Pharmaceuticals (RIGL) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $101.69M | $48.14M | 35.4 % |
| Q1 | 2025-05-06 | $53.30M | $51.16M | 21.5 % |
| Q4 | 2025-03-04 | $57.60M | $48.32M | 0.01 % |
| Q3 | 2024-11-07 | $55.31M | $41.93M | 31.9 % |
PREGUNTAS FRECUENTES
¿Cuándo Rigel Pharmaceuticals (NASDAQ:RIGL) publicará los resultados?
Está previsto que Rigel Pharmaceuticals (RIGL) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 5, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Rigel Pharmaceuticals (NASDAQ:RIGL)?
El BPA real fue de $3.28, que superó la estimación de $0.19.
¿Cuáles fueron los ingresos de Rigel Pharmaceuticals (NASDAQ:RIGL)?
Los ingresos reales fueron $101.7M, que superó la estimación de $48.1M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.